Fibrosis in connective tissue disease: the role of the myofibroblast and fibroblast-epithelial cell interactions

Fibrosis, characterized by excessive extracellular matrix accumulation, is a common feature of many connective tissue diseases, notably scleroderma (systemic sclerosis). Experimental studies suggest that a complex network of intercellular interactions involving endothelial cells, epithelial cells, fibroblasts and immune cells, using an array of molecular mediators, drives the pathogenic events that lead to fibrosis. Transforming growth factor-β and endothelin-1, which are part of a cytokine hierarchy with connective tissue growth factor, are key mediators of fibrogenesis and are primarily responsible for the differentiation of fibroblasts toward a myofibroblast phenotype. The tight skin mouse (Tsk-1) model of cutaneous fibrosis suggests that numerous other genes may also be important.

[1]  D. Rockey,et al.  Cell and molecular regulation of endothelin-1 production during hepatic wound healing. , 2003, Molecular biology of the cell.

[2]  B. Hinz,et al.  Myofibroblasts and mechano-regulation of connective tissue remodelling , 2002, Nature Reviews Molecular Cell Biology.

[3]  D. Brigstock,et al.  Connective tissue growth factor: what's in a name? , 2000, Molecular genetics and metabolism.

[4]  R. Lafyatis,et al.  Mutant fibrillin 1 from tight skin mice increases extracellular matrix incorporation of microfibril-associated glycoprotein 2 and type I collagen. , 2004, Arthritis and rheumatism.

[5]  C. Denton,et al.  Scleroderma--clinical and pathological advances. , 2004, Best practice & research. Clinical rheumatology.

[6]  Hannu Kautiainen,et al.  Arthritis Research & Therapy , 2009 .

[7]  FernandoRodríguez-Pascual,et al.  Functional Cooperation Between Smad Proteins and Activator Protein-1 Regulates Transforming Growth Factor-β–Mediated Induction of Endothelin-1 Expression , 2003 .

[8]  E. Greene,et al.  TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells. , 2002, American journal of physiology. Renal physiology.

[9]  T. Slowinski,et al.  Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. , 1997, The Journal of clinical investigation.

[10]  A. Branzi,et al.  The endothelin system in pulmonary arterial hypertension. , 2004, Cardiovascular research.

[11]  M. Inaoki,et al.  Connective tissue growth factor causes persistent proα2(I) collagen gene expression induced by transforming growth factor‐β in a mouse fibrosis model , 2005 .

[12]  F. Hirche,et al.  Interactions of primary fibroblasts and keratinocytes with extracellular matrix proteins: contribution of alpha2beta1 integrin. , 2006, Journal of cell science.

[13]  Oliver Distler,et al.  Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis. , 2007, Arthritis and rheumatism.

[14]  A. Ghahary,et al.  Interaction of keratinocytes and fibroblasts modulates the expression of matrix metalloproteinases-2 and -9 and their inhibitors , 2005, Molecular and Cellular Biochemistry.

[15]  M. Clozel,et al.  Role of endothelin in fibrosis and anti‐fibrotic potential of bosentan , 2005, Annals of medicine.

[16]  F. Hirche,et al.  Interactions of primary fibroblasts and keratinocytes with extracellular matrix proteins: contribution of α2β1 integrin , 2006, Journal of Cell Science.

[17]  E. Schiffrin,et al.  Myocardial Fibrosis in DOCA-Salt Hypertensive Rats: Effect of Endothelin ETA Receptor Antagonism , 2000, Circulation.

[18]  Jesús Prieto,et al.  Topical application of a peptide inhibitor of transforming growth factor-beta1 ameliorates bleomycin-induced skin fibrosis. , 2005, The Journal of investigative dermatology.

[19]  Wei Hu,et al.  Angiopoietin-related growth factor (AGF) supports adhesion, spreading, and migration of keratinocytes, fibroblasts, and endothelial cells through interaction with RGD-binding integrins. , 2006, Biochemical and biophysical research communications.

[20]  M. Mayes.  Endothelin and endothelin receptor antagonists in systemic rheumatic disease. , 2003, Arthritis and rheumatism.

[21]  J. Lasky,et al.  Interstitial fibrosis and growth factors. , 2000, Environmental health perspectives.

[22]  T. Yamamoto,et al.  Bleomycin increases steady-state levels of type I collagen, fibronectin and decorin mRNAs in human skin fibroblasts , 2000, Archives of Dermatological Research.

[23]  S. Werner,et al.  Regulation of wound healing by growth factors and cytokines. , 2003, Physiological reviews.

[24]  M. Inaoki,et al.  Connective tissue growth factor causes persistent proalpha2(I) collagen gene expression induced by transforming growth factor-beta in a mouse fibrosis model. , 2005, Journal of cellular physiology.

[25]  S. Werner,et al.  Paracrine regulation of keratinocyte proliferation and differentiation. , 2001, Trends in cell biology.

[26]  D. Abraham,et al.  Mechanisms and consequences of fibrosis in systemic sclerosis , 2006, Nature Clinical Practice Rheumatology.

[27]  T. Yoshikawa,et al.  SKL-2841, a dual antagonist of MCP-1 and MIP-1 beta, prevents bleomycin-induced skin sclerosis in mice. , 2007, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[28]  S. Jimenez,et al.  A tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation. , 1996, Genome research.

[29]  H. Neumayer,et al.  Pulmonary fibrosis and chronic lung inflammation in ET-1 transgenic mice. , 2000, American Journal of Respiratory Cell and Molecular Biology.

[30]  D. Abraham,et al.  Hammerhead ribozyme-mediated silencing of the mutant fibrillin-1 of tight skin mouse: insight into the functional role of mutant fibrillin-1. , 2006, Experimental cell research.

[31]  B. Hinz,et al.  Dissecting the roles of endothelin,TGF-β and GM-CSF on myofibroblast differentiation by keratinocytes , 2004, Thrombosis and Haemostasis.

[32]  J. Horowitz,et al.  Effects of the Protein Kinase Inhibitor, Imatinib Mesylate, on Epithelial/Mesenchymal Phenotypes: Implications for Treatment of Fibrotic Diseases , 2007, Journal of Pharmacology and Experimental Therapeutics.

[33]  R. Lafyatis,et al.  Fibulin-2 and fibulin-5 alterations in tsk mice associated with disorganized hypodermal elastic fibers and skin tethering. , 2004, The Journal of investigative dermatology.

[34]  MartaRuiz-Ortega,et al.  Endothelin-1, via ETA Receptor and Independently of Transforming Growth Factor-β, Increases the Connective Tissue Growth Factor in Vascular Smooth Muscle Cells , 2005 .

[35]  R. D. du Bois,et al.  Constitutive ALK5-Independent c-Jun N-Terminal Kinase Activation Contributes to Endothelin-1 Overexpression in Pulmonary Fibrosis: Evidence of an Autocrine Endothelin Loop Operating through the Endothelin A and B Receptors , 2006, Molecular and Cellular Biology.

[36]  T. Krieg,et al.  Myofibroblast differentiation is induced in keratinocyte-fibroblast co-cultures and is antagonistically regulated by endogenous transforming growth factor-beta and interleukin-1. , 2004, The American journal of pathology.

[37]  M. Redondo-Horcajo,et al.  Transforming growth factor-beta receptor requirements for the induction of the endothelin-1 gene. , 2006 .